BenQ Medical Technology Corporation (TPEX:4116)
41.55
+0.15 (0.36%)
May 13, 2025, 1:02 PM CST
BenQ Medical Technology Revenue
BenQ Medical Technology had revenue of 1.23B TWD in the quarter ending March 31, 2025, with 16.16% growth. This brings the company's revenue in the last twelve months to 4.94B, up 8.62% year-over-year. In the year 2024, BenQ Medical Technology had annual revenue of 4.77B with 4.94% growth.
Revenue (ttm)
4.94B
Revenue Growth
+8.62%
P/S Ratio
0.37
Revenue / Employee
12.19M
Employees
405
Market Cap
1.85B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.77B | 224.35M | 4.94% |
Dec 31, 2023 | 4.54B | 166.50M | 3.80% |
Dec 31, 2022 | 4.38B | 2.91B | 198.82% |
Dec 31, 2021 | 1.46B | 63.74M | 4.55% |
Dec 31, 2020 | 1.40B | 20.56M | 1.49% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |